Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Phase 3b/4 study
-
Could a Phase 3b/4 study be considered under the RWE guidance? or under the Guidance Regarding Duration of Clinical Trials Used as Reference Support in Advertising?
-
Hello @tk2022
The feature of being phase 3b/4 does not in and of itself disqualify a study from either RWE or study duration.
